• Evidence-based psychedelic therapy: driven by science, away from bogus spiritual fixes

    Dr Henrik Jungaberle covers the INSIGHT 2023 themes, and the importance of scientific rigour in the expanding field of psychedelic therapy.

  • MDMA: a new hope for young people with PTSD

    Research is evaluating risks and suitability of MDMA assisted therapy for 15-17 year olds with PTSD. Ethically rigorous studies are needed to evaluate safety and efficacy.

  • Psilocybin: new therapeutic perspectives

    The two pilot studies, one on depression in Alzheimer's and one on Lyme disease, assess if psilocybin offers alternatives to ineffective standard treatments.

  • New ESC Guidelines 2023: An overview

    Five new guidelines were presented in the ESC Congress: acute coronary syndromes; heart failure; cardiomyopathies; cardio-vascular disease and diabetes; and endocarditis.

  • Interview: Psychedelic therapy in Italy, a long road ahead

    Where does Italy stand in psychedelic drug research? We discuss this with Dr Matteo Buonarroti, the first Italian doctor to complete the Mind Foundation's Augmented Psychotherapy Training.

  • ESC guidelines for all acute coronary syndromes published

    Cardiovascular events are the number one cause of death. Guidelines for all acute coronary syndromes have been published just in time for the 2023 ESC Congress.

  • The ZePrion experiment: set in space to fight diseases on earth

    The experiment, sent to the ISS, looks into the molecular mechanism behind an innovative pharmaceutical protocol to combat prion diseases.

  • Analysis: First aid in case of drowning

    Drowning deaths are a serious public health problem worldwide. Drowning victims require rapid and skilled intervention.

  • How does neutropenia increase the risk of AML and MDS?

    Severe congenital neutropenia increases the risk of myelodysplastic syndrome and acute myeloid leukaemia. What do we know today about the haematological processes that lead to leukaemogenesis?

  • Transthyretin amyloid cardiomyopathy (ATTR-CM): A promising new antibody

    No drug tackled the cause of ATTR-CM - the deposition of misfolded transthyretin in the heart muscle tissue. Until a phase I study tested a new recombinant antibody.

  • Thrombosis prophylaxis: a longer treatment is often better

    A meta-analysis examined the timing of postoperative thromboembolic events. What are the implications of this research for treatments?

  • 10 pesticides that are neurotoxic and involved in Parkinson's disease

    More data suggests a link between exposure to environmental toxins such as pesticides and heavy metals, and the rise of Parkinson's disease.

  • Therapy-resistant hypertension: Renal denervation is a treatment option

    Recent studies show the benefit of renal denervation in severe or refractory hypertension. The ESH has started recommending it for some patients.

  • Long-term therapy of hepatits B with NUCs: obstacle to functional cure?

    Ending long-term therapy of HBeAg-negative hepatitis B with NUC was believed to induce a functional cure. Data on this was very limited, until a new study.

  • Scurvy: Portrait of a serial killer

    A short history of a silent serial killer that we thought we'd got rid of in the 19th century, thanks to the Royal Navy, and a fair amount of empirical observations.

  • Printing a skin replacement: The possibilities of 3-D technologies in dermatology

    Dermatology may experience wide new tech applications, even more than other specialties. Although still in their early stages, 3D innovations are promising.

  • Forest fires: Assessing the health risks posed by the smoke

    Smoke from forest fires is more toxic than "normal" air pollution, can remain in the air for a long time and travel very long distances.

  • Interview: The role of the microbiome in haematology

    The microbiome is crucial for immunity, metabolic homeostasis, and protection from pathogens. What about its role in haematological diseases?

  • New hopes for chronic inflammatory bowel diseases?

    Two recent studies look at the efficacy of mirikizumab and upadacitinib in ulcerative colitis and Crohn's disease. Can IBD patients benefit?

  • TikTok in adolescence: Is it impacting the health of a generation?

    There is a recent controversy about the influence and use of social media among children and young people. What are the biggest dangers and opportunities?

  • 11 |
  • 12 |
  • 13 |
  • 14 |
  • 15 |
  • 16 |
  • 17 |
  • 18 |
  • 19 |
  • 20 |
  • 21 |